Search Results - "Jouneau, S"

Chest CT in COVID-19 pneumonia: A review of current knowledge by Jalaber, C., Lapotre, T., Morcet-Delattre, T., Ribet, F., Jouneau, S., Lederlin, M.

“…•Unenhanced chest CT is indicated for patients with suspected COVID-19 presenting with dyspnea, polypnea or arterial blood oxygen desaturation.•Most typical CT…”
Get full text

Skin manifestations among GATA2‐deficient patients by Polat, A., Dinulescu, M., Fraitag, S., Nimubona, S., Toutain, F., Jouneau, S., Poullot, E., Droitcourt, C., Dupuy, A.

“…Summary GATA2 mutations have been identified in various diseases, such as MonoMAC syndrome, Emberger syndrome, familial myelodysplastic syndrome, acute myeloid…”
Get full text

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Dominique, S, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Tiev, K.P, Vittecoq, O, Noel, D, Mouthon, L, Menard, J.-F, Jouen, F

“…Abstract The aims of the present study were to: compare the characteristics between antisynthetase syndrome (ASS) patients with anti-Jo1 antibody and those…”
Get full text

Spirometry practice by French general practitioners between 2010 and 2018 in adults aged 40 to 75 years by Chapron, A., Lemée, T., Pau, G., Jouneau, S., Kerbrat, S., Balusson, F., Oger, E.

“…In France, most spirometries are performed by pneumologists. Spirometry is difficult to access due to the distance to medical office and long delays for…”
Get full text

Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials by Lescoat, A, Jouneau, S, Uzunhan, Y, Jégo, P, Cottin, V, Hachulla, E

“…Systemic sclerosis (SSc) is an autoimmune disease associated to fibrotic manifestations. Interstitial lung disease (SSc-ILD), one of the main fibrotic features…”
Get full text

Hypersensitivity Pneumonitis: An update by Chauvin, P, Kerjouan, M, Jégo, P, Jouneau, S, Lescoat, A

“…Hypersensitivity Pneumonitis (HP) is a common immune-mediated interstitial lung disease (ILD) induced by repeated exposure to environmental antigens in…”
Get full text

Incidence and characteristics of nosocomial influenza in a country with low vaccine coverage by Luque-Paz, D., Pronier, C., Bayeh, B., Jouneau, S., Grolhier, C., Le Bot, A., Bénézit, F., Thibault, V., Tattevin, P.

“…Influenza vaccination coverage is low in France, in at-risk patients and in healthcare workers. We aimed to estimate the incidence of nosocomial influenza, its…”
Get full text

Idiopathic pulmonary fibrosis diagnosed concomitantly with diffuse squamous cell lung cancer on surgical lung biopsy: a case report by Niel, C, Ricordel, C, Guy, T, Kerjouan, M, De Latour, B, Chiforeanu, D, Lederlin, M, Jouneau, S

“…Idiopathic pulmonary fibrosis is a disease with a poor prognosis and has been associated with increased lung cancer incidence. We report the case of a…”
Get full text

Drug‐induced granulomatosis: is dupilumab the new kid on the block? by Belhomme, N., Gaignon, T., Jouneau, S., Misery, L., Abasq‐Thomas, C., Cador, B., Lecureur, V., Cadiou, S., Ballerie, A., Polard, E., Mensi, S., Jego, P., Lescoat, A.

“…Dupilumab is an IgG4 antibody directed toward IL-4 and IL-13, two major effectors of the Th2 immunity response. It was originally developed for severe and/or…”
Get full text

Triggering factors of acute COPD exacerbations by Jouneau, S

Get more information

Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series by Droitcourt, C., Adamski, H., Polat, A., Polard, E., Kerjouan, M., Arnouat, B., Le Garrec, M., Oger, E., Dupuy, A., Jouneau, S.

“…The oral antifibrotic agent, pirfenidone (PFD), 5-methyl-l-phenyl-[1H]-pyridine, is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and fatal lung…”
Get full text

Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma by Macedo, P., Hew, M., Torrego, A., Jouneau, S., Oates, T., Durham, A., Chung, K. F.

“…Summary Background About 5–10% of patients with asthma suffer from poorly‐controlled disease despite corticosteroid (CS) therapy. Objective We determined…”
Get full text

Conservative management of primary spontaneous pneumothorax: A failed revolution? by Jouneau, S., Sohier, L., Bazin, Y., Salé, A., Messika, J.

Get full text

Radiology residents’ skill level in chest x-ray reading by Fabre, C., Proisy, M., Chapuis, C., Jouneau, S., Lentz, P.-A., Meunier, C., Mahé, G., Lederlin, M.

“…To evaluate the mean skill level of radiology residents in chest X-ray (CXR) reading, with regard to cognitive mechanisms involved in this task and to…”
Get full text

Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases by Bernard, C, Maucort-Boulch, D, Varron, L, Charlier, C, Sitbon, K, Freymond, N, Bouhour, D, Hot, A, Masquelet, A C, Valeyre, D, Costedoat-Chalumeau, N, Etienne, M, Gueit, I, Jouneau, S, Delaval, P, Mouthon, L, Pouget, J, Serratrice, J, Brion, J-P, Vaylet, F, Bremont, C, Chennebault, J M, Jaffuel, S, Broussolle, C, Lortholary, O, Sève, P

“…To describe the main characteristics and the treatment of cryptococcosis in patients with sarcoidosis. Multicenter study including all patients notified at the…”
Get full text

French practical guidelines for the diagnosis and management of IPF - 2021 update, short version by Cottin, V, Bonniaud, P, Cadranel, J, Crestani, B, Jouneau, S, Marchand-Adam, S, Nunes, H, Wémeau-Stervinou, L, Bergot, E, Blanchard, E, Borie, R, Bourdin, A, Chenivesse, C, Clément, A, Gomez, E, Gondouin, A, Hirschi, S, Lebargy, F, Marquette, C-H, Montani, D, Prévot, G, Quetant, S, Reynaud-Gaubert, M, Salaun, M, Sanchez, O, Trumbic, B, Berkani, K, Brillet, P-Y, Campana, M, Chalabreysse, L, Chatté, G, Debieuvre, D, Ferretti, G, Fourrier, J-M, Just, N, Kambouchner, M, Legrand, B, Le Guillou, F, Lhuillier, J-P, Mehdaoui, A, Naccache, J-M, Paganon, C, Rémy-Jardin, M, Si-Mohamed, S, Terrioux, P

“…Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated. Under the…”
Get more information

Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Hachulla, E, Vittecoq, O, Menard, J.-F, Jouen, F, Dominique, S

“…Abstract Background The aims of the present study were to determine both clinical manifestations and outcome of anti-PL7 patients with antisynthetase syndrome…”
Get full text

Primary Spontaneous Pneumothorax - Guidelines ready for take-off! by Messika, J, Maitre, B, Roche, N, Jouneau, S

Get more information

Distinctive features between community-acquired pneumonia (CAP) due to Chlamydophila psittaci and CAP due to Legionella pneumophila admitted to the intensive care unit (ICU) by Gacouin, A., Revest, M., Letheulle, J., Fillatre, P., Jouneau, S., Piau, C., Uhel, F., Tattevin, P., Le Tulzo, Y.

“…The spectrum of community-acquired pneumonia (CAP) due to Chlamydophila psittaci ranges from mild, self-limited CAP, to acute respiratory failure. We performed…”
Get full text

Features distinguishing ornithosis from avian acute hypersensitivity pneumonitis - a retrospective analysis by Jézéquel, A, Jouneau, S, Bouju, P, Letheulle, J, Kerjouan, M, Gacouin, A

“…The aim of our study was to compare the features at diagnosis in patients with ornithosis to patients with avian acute hypersensitivity pneumonitis (HP)…”
Get more information